whatshot

KNSA   $21.26  0.81% Market Closed After Close 21.4 0.66%

Kiniksa Pharmaceuticals Ltd
show_chart Advanced Chart of KNSA
Last Events:

2023-08-09 Signal in MACD changed from bullish weakening to bearish reversal. Oscillator MACD is in the positive territory it crossed the signal line from the top and falls. These factors mean that the market confirms the end of the upward trend. Last signal: main and signal line crossing.

2023-08-05 Trend pattern changed from сужающийся канал to расходящийся клин с наклоном вверх.

2023-08-05 Signal in MACD changed from bullish recovery to bullish weakening. Oscillator MACD is in the positive territory it's higher than the signal line and falls. These factors mean that the growing trend persists, but the growth rate is declining. Last signal: entrance to the overbought zone.

2023-08-05 Signal in RSI changed from bullish recovery to bullish weakening. RSI indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: entrance to the overbought zone.

2023-08-04 Signal in Stochastic changed from bullish weakening to bearish. The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: down-crossing the middle level.

2023-08-04 Trend changed from linear up to flat and up.

2023-08-03 Trend pattern changed from расходящийся клин с наклоном вверх to сужающийся канал.

2023-08-03 Signal in RSI changed from bullish weakening to bullish recovery. RSI indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: entrance to the overbought zone.

Current temperature: 6.48
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 6
Target Price Mean 36.00
Mean unverified/preliminary 36.00 / 36.00
Target Price Low / High 32.00 / 40.00
Median / STD DEV 35.00 / 3.29
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total None ActivelyBuy ActivelyBuy
rsi ActivelyBuy ActivelyBuy Buy
macd None None None
stoch None None None
ma20 Sell None None
ma50 None None None
ma100 None Buy ActivelyBuy
Candlestick PatternNov. 11, 2024 Shooting Star - is a candlestick that has a small body, a long upper shadow and a little or no lower tail. Considered to be a bearish pattern in an uptrend.
ISIN GB00BRXB0C07
ceo Mr. Sanj K. Patel
Website https://www.kiniksa.com
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody inhibitor that completed Phase II clinical trials for the treatment of giant cell arteritis; Vixarelimab, a monoclonal antibody, that is in Phase 2b clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-404, a monoclonal antibody inhibitor of the CD40- CD154 interaction, a T-cell co-stimulatory signal critical for B-cell maturation, immunoglobulin class switching, and type 1 immune response. The company was formerly known as Kiniksa Pharmaceuticals, Ltd and changed its name tpKiniksa Pharmaceuticals International, plc in June 2024. The company was incorporated in 2015 and is based in London, the United Kingdom.